Design, Test, Repeat: Paths to Elicit Neutralizing Antibodies - A virtual Mini Symposium
May 2015
Introduction
Bargavi Thyagarajan, Global HIV Vaccine Enterprise
Chair
Robin Shattock, Imperial College London
HIV-1 antibody lineages: Implications for vaccine design
John Mascola, Vaccine Research Center, NIAID, NIH
Sequential Env Immunisations as a Path to an HIV Vaccine
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Native Flexibly Linked Well-ordered Trimers
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
Diversity of HIV-1 Env Vaccine-Induced Antibody Responses
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Moderator
Penny Moore, National Institute for Communicable Diseases South Africa
Robin Shattock, Imperial College London
Panelist
John Mascola, Vaccine Research Center, NIAID, NIH
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
